San-El Mühendislik (SANEL) becomes partner in dialysis company

Salacak Sağlık Yatırımları AŞ, in which San-El Mühendislik holds a 48.90% stake, has signed a share transfer agreement to acquire a 50% stake in Uşakcan Diyaliz Hizmetleri AŞ for 74 million TL. Through this transaction, San-El Mühendislik indirectly becomes a partner in the dialysis services sector. Salacak Sağlık Yatırımları AŞ strengthens its presence in the healthcare sector by acquiring half of Uşakcan Diyaliz Hizmetleri AŞ. San-El Mühendislik's investment in dialysis services via this subsidiary is considered a significant step in portfolio diversification. With the signing of the share transfer agreement, San-El Mühendislik's activity in the healthcare sector increases. Although listed in the construction index, the company is moving into a different field through healthcare investments. This is not investment advice.

📊 SANEL — Piyasa Yorumu

■ neutral · 50%

The news announces SANEL's entry into the dialysis sector, a strategic move that may be viewed positively in the medium term, though the short-term price impact remains uncertain. Technical indicators present mixed signals: RSI is neutral at 50, MACD is just below the signal line, and the price is trading below both the 20-day and 50-day moving averages. The recent 4.94% decline at the last close suggests selling pressure immediately following the announcement. With no clear short-term direction, a neutral stance is recommended.

RSI 14

50.2

MACD

0.75

24h Δ

-4.94%

Canlı Grafikler